Literature DB >> 10793440

Tilt training: a treatment for malignant and recurrent neurocardiogenic syncope.

T Reybrouck1, H Heidbüchel, F Van de Werf, H Ector.   

Abstract

The treatment of neurocardiogenic syncope is insufficient in many cases. We hypothesized that the repeated exposure of the cardiovascular system to orthostatic stress could have a therapeutic effect on the regulation of cardiovascular reflex mechanisms. We have started a program of tilt training for heavily symptomatic patients. After hospital admission, patients were tilted daily (60-degree inclination), until syncope, or until a maximum of 45-90 minutes. The patients were instructed to continue a program of daily tilt training at home: two 30-minute sessions of upright standing against a vertical wall. No medication was prescribed. A total of 260 tilt table sessions were performed in 42 patients. The first tilt test was positive after 21 +/- 13 minutes. The syncope was cardioinhibitory in 14 cases, vasodepressor in 19, mixed in 9. At the time of hospital discharge, 41 patients could support 45 minutes of head-up tilting. After a mean follow-up time of 15.1 (SD 7.8) months, 36 patients remained completely free of syncope. Syncope still occurred in one patient and presyncope in four patients. One patient died from an extensive myocardial infarction. The abnormal autonomic reflex activity of neurocardiogenic syncope can be remedied by a program of continued tilt training without the administration of drugs. This new treatment has proven to be effective for the vasodepressor and the cardioinhibitory type of syncope.

Entities:  

Mesh:

Year:  2000        PMID: 10793440     DOI: 10.1111/j.1540-8159.2000.tb00833.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  12 in total

1.  Determining the optimal pacing intervention rate for vasovagal syncope.

Authors:  A S Kurbaan; A C Franzén; Z Stack; D Heaven; G Mathur; R Sutton
Journal:  J Interv Card Electrophysiol       Date:  2000-12       Impact factor: 1.900

2.  Dizziness and syncope in adolescence.

Authors:  K A McLeod
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

3.  Beta blockade in neurocardiogenic dysfunction: results of a clinical study.

Authors:  M R P Baselier; A A van den Bos
Journal:  Neth Heart J       Date:  2001-10       Impact factor: 2.380

Review 4.  Strategy for the management of vasovagal syncope.

Authors:  Daniel M Bloomfield
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 5.  Neurocardiogenic syncope in children : current concepts in diagnosis and management.

Authors:  Martial Massin
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 6.  New approaches to the treatment and prevention of neurally mediated reflex (neurocardiogenic) syncope.

Authors:  Daniel P Melby; Joseph A Cytron; David G Benditt
Journal:  Curr Cardiol Rep       Date:  2004-09       Impact factor: 2.931

Review 7.  Syncope in childhood.

Authors:  K A McLeod
Journal:  Arch Dis Child       Date:  2003-04       Impact factor: 3.791

8.  Tilt table test: state of the art.

Authors:  Gonzalo Barón-Esquivias; Antoni Martínez-Rubio
Journal:  Indian Pacing Electrophysiol J       Date:  2003-10-01

9.  Self-controllable prodromal symptoms of syncope attributed to carotid sinus syndrome during the end stage of cancer: a case report.

Authors:  Hideaki Hasuo; Kenji Kanbara; Hiroko Sakuma; Rie Matsumori; Mikihiko Fukunaga
Journal:  Biopsychosoc Med       Date:  2016-09-05

10.  Self-reported post-exertional fatigue in Gulf War veterans: roles of autonomic testing.

Authors:  Mian Li; Changqing Xu; Wenguo Yao; Clare M Mahan; Han K Kang; Friedhelm Sandbrink; Ping Zhai; Pamela A Karasik
Journal:  Front Neurosci       Date:  2014-01-07       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.